Mounjaro (tirzepatide) has one of the most dramatic weight loss profiles of any GLP-1 medication — clinical trials showed average losses of 20%+ of body weight at the 15mg dose. But the journey from 2.5mg to 15mg takes months of careful dose escalation, weekly injections, and consistent tracking. Shotly is a Mounjaro tracker for iPhone purpose-built for this journey: log every injection, watch your weight chart slope down week by week, and keep your nutrition on track even as your appetite drops.
Start Tracking Your Mounjaro JourneyMounjaro starts at 2.5mg weekly for 4 weeks, then escalates to 5mg, 7.5mg, 10mg, 12.5mg, and finally 15mg — each held for at least 4 weeks before increasing. Shotly tracks your current dose and escalation history. Every injection log shows which phase of your protocol you were in. You'll always know your current dose and when you started it.
Tirzepatide is a subcutaneous injection — rotating sites reduces local reactions and improves absorption. Shotly includes a body map for logging abdomen, left thigh, right thigh, left arm, and right arm. Your injection site history shows when you last used each location, making rotation straightforward.
Log your weight weekly and Shotly plots the full trend. Total lost from start weight, average weekly rate, and percentage progress toward goal are all calculated automatically. The chart makes months of progress visible at once — especially motivating on Mounjaro, where the dose escalation often produces distinct acceleration phases in the weight loss curve.
At higher Mounjaro doses, appetite suppression is significant. The risk is muscle loss from inadequate protein intake. Shotly's meal logger flags when your daily protein falls below your goal (default: 120g). Log meals in seconds with automatic calorie and macro tracking. Fiber targets matter too — GLP-1 medications slow gastric emptying, and adequate fiber supports gut motility.